Type 1 receptor tyrosine kinase profiles identify patients with enhanced benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial.
| Autor: | Bartlett JM, Munro A, Cameron DA, Thomas J, Prescott R, Twelves CJ |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 11/1/2008, Vol. 26 Issue 31, p5027-5035, 9p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|